| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | AQST Aquestive Therapeutics, Inc. | Jung Cassie | Chief Operating Officer | Sell | 44 | $4.87 | $214.06 | -100% | -39.2% | +27.5% | |
| Nov 26, 2024 | ANIP Ani Pharmaceuticals Inc | Lalwani Nikhil66 | President &CEO | Sell | 33,481 | $57.99 | $1,941,442.30 | -4.3% | -4.0% | +45.8% | |
| Nov 26, 2024 | GTBIF Green Thumb Industries Inc. | Kravitz Bret | General Counsel And Secretary | Sell | 5,938 | $9.10 | $54,039.34 | -0.4% | - | - | |
| Nov 25, 2024 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $372.75 | $3,727,546.89 | -23.9% | -2.8% | +31.8% | |
| Nov 25, 2024 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 101,993 | $29.62 | $3,021,496.10 | -12.3% | +63.7% | +18.3% | |
| Nov 25, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 17,303 | $26.49 | $458,356.47 | -8.6% | +63.7% | +18.3% | |
| Nov 25, 2024 | ZTS Zoetis Inc. | Polzer Robert J59 | Executive Vice President | Sell | 3,477 | $177.46 | $617,028.42 | -51.7% | -7.5% | -28.4% | |
| Nov 22, 2024 | AMRX Amneal Pharmaceuticals, Inc. | Kiely John | Director | Sell | 17,058 | $8.38 | $142,946.04 | -6.0% | -6.2% | +42.4% | |
| Nov 22, 2024 | AMRX Amneal Pharmaceuticals, Inc. | Autor Deborah M. | Director | Sell | 40,000 | $8.35 | $334,073.97 | -22.2% | -6.2% | +42.4% | |
| Nov 22, 2024 | INIS International Isotopes Inc | Cox W Matthew | Chief Financial Officer | Buy | 90,000 | $0.03 | $3,000.00 | +5.5% | - | - | |
| Nov 21, 2024 | TCNNF Trulieve Cannabis Corp. | May Richard S. | Director | Buy | 1,610 | $6.05 | $9,740.50 | +0.3% | - | - | |
| Nov 21, 2024 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 7,700 | $367.36 | $2,828,672.00 | -17.3% | +3.7% | +29.3% | |
| Nov 21, 2024 | AMRX Amneal Pharmaceuticals, Inc. | Daly Jason B. | SVP, Chief Legal Officer | Sell | 13,665 | $8.40 | $114,786.00 | -100% | -5.6% | +43.6% | |
| Nov 21, 2024 | TCNNF Trulieve Cannabis Corp. | Healy Peter | Director | Buy | 8,130 | $6.05 | $49,186.50 | +36.1% | - | - | |
| Nov 21, 2024 | TCNNF Trulieve Cannabis Corp. | Morreau Jane C | Director | Buy | 1,235 | $6.06 | $7,484.10 | +5.5% | - | - | |
| Nov 21, 2024 | TCNNF Trulieve Cannabis Corp. | May Richard S. | Director | Buy | 1,160 | $6.05 | $7,018.00 | +0.2% | - | - | |
| Nov 20, 2024 | TCNNF Trulieve Cannabis Corp. | Thronson Susan | Director | Buy | 3,968 | $6.30 | $24,998.40 | +68.7% | - | - | |
| Nov 20, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Fox Christine | EVP, Head Of U.s. Commercial | Sell | 19,388 | $16.87 | $327,085.25 | -30.5% | -2.7% | +42.6% | |
| Nov 20, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 75,102 | $0.17 | $12,871.32 | - | - | - | |
| Nov 20, 2024 | INIS International Isotopes Inc | Bagerdjian Shahe | Pres. &CEO | Buy | 100,000 | $0.04 | $4,000.00 | +1.1% | - | - | |
| Nov 20, 2024 | TCNNF Trulieve Cannabis Corp. | Thronson Susan | Director | Buy | 3,968 | $6.30 | $24,998.40 | +17.6% | - | - | |
| Nov 20, 2024 | MIRA Mira Pharmaceuticals, Inc. | Aminov Erez51 | Chief Executive Officer | Sell | 100,000 | $1.34 | $133,649.20 | -4.4% | -9.9% | +6.7% | |
| Nov 19, 2024 | TCNNF Trulieve Cannabis Corp. | Millner Thomas L | Director | Buy | 8,000 | $6.12 | $48,960.00 | +35.6% | - | - | |
| Nov 19, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 7,500 | $22.00 | $165,000.00 | -3.9% | +148.6% | +52.3% | |
| Nov 19, 2024 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 197 | $2.17 | $426.51 | -0.1% | -22.4% | +15.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.